Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
The Breast Journal|January 1, 2025
Evaluating DNA Methylation in Random Fine Needle Aspirates from the Breast to Inform Cancer RiskKala Visvanathan, Ashley Cimino-Mathews, Mary Jo Fackler, et al.
Cancer Research|August 10, 2011
Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrenceMary Jo Fackler, Christopher B Umbricht, Danielle Williams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2008
Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastasesJulie M Wu, Mary Jo Fackler, Marc K Halushka, et al.
NPJ Breast Cancer|July 8, 2021
Automated and rapid detection of cancer in suspicious axillary lymph nodes in patients with breast cancerJuanjuan Li, Bradley M Downs, Leslie M Cope, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 5, 2016
Gene Methylation and Cytological Atypia in Random Fine-Needle Aspirates for Assessment of Breast Cancer RiskVered Stearns, Mary Jo Fackler, Sidra Hafeez, et al.
Clinical Epigenetics|April 20, 2024
Discovery and technical validation of high-performance methylated DNA markers for the detection of cervical lesions at risk of malignant progression in low- and middle-income countriesMary Jo Fackler, Madison Pleas, Youran Li, et al.
Cancer Research|April 17, 2014
Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancerMary Jo Fackler, Zoila Lopez Bujanda, Christopher Umbricht, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2022
Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective TrialKala Visvanathan, Leslie Cope, Mary Jo Fackler, et al.
Cancer Research Communications|September 1, 2022
Development of an automated liquid biopsy assay for methylated markers in advanced breast cancerMary Jo Fackler, Suzana Tulac, Neesha Venkatesan, et al.
Oncotarget|September 11, 2015
Global phosphotyrosine survey in triple-negative breast cancer reveals activation of multiple tyrosine kinase signaling pathwaysXinyan Wu, Muhammad Saddiq Zahari, Binyun Ma, et al.
Pageof 5